ArticleBMC psychiatry2025
Multi-system biomarkers of suicide risk in major depressive disorder: integrating erythroid parameters, composite inflammatory indices, and metabolic dysregulation.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association Between Peripheral Inflammatory and Hematological Markers and Suicide Attempts: A Retrospective Case-Control Study.Psychiatry investigation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMajor Depressive Disorder (MDD) drives global disability burden with suicide as a critical concern, yet multi-system biomarkers integrating erythroid, inflammatory, and metabolic pathways for suicide risk stratification remain underexplored.
methodsThis cross-sectional study analyzed 357 DSM-Ⅴ diagnosed MDD patients, excluding acute infections, autoimmune disorders, immunomodulatory treatments, or malignancy. Fasting blood samples quantified erythroid parameters, inflammatory indices including pan-immune-inflammation value (PIV), the triglyceride glucose (TyG) index calculated as ln (TG×FBG/2), and thyroid hormones. Patients’ suicide risk was assessed via structured interviews, and were categorized into three groups: non-suicidal ideation (non-SI), suicidal ideation (SI) only, and suicide attempt (SA) history.
resultsMDD patients with suicidal tendencies showed significantly higher unmarried proportions, red blood cell counts, years of schooling, logPIV, and mood stabilizer use alongside lower age, triglyceride glucose index, fasting glucose, thyroxine, and hypertension prevalence versus patients without suicidal tendencies. Binary regression identified logPIV and more complex conditions (use of mood stabilizers) as risk factors with odds ratios (OR) of 2.38 and 3.86 respectively, while marriage reduced risk (OR = 0.29). Ordinal regression across suicide risk tiers confirmed illness duration, logPIV, and more complex conditions (use of mood stabilizers) as escalating risk predictors, whereas marriage remained protective. Combined discriminatory performance (AUC) of disease duration, years of schooling, logPIV, TyG index, T4 levels, marital status, hypertension, and mood stabilizer usage was 0.64 (non-SI vs. SI), 0.82 (SI vs. SA), and 0.85 (non-SI vs. SA).
conclusionDysregulated inflammation via logPIV, metabolic dysfunction, marital status, and mood stabilizer use constitute validated biomarkers for suicide risk stratification, supporting integrated multi-system models for early clinical intervention. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.